The Future of Diabetic Retinopathy Management with Artificial Intelligence & Diagnostic Imaging

The future management and treatment of diabetic retinopathy (DR) will increasingly rely on longitudinal clinical data via various imaging technologies and artificial intelligence (AI) platforms. As ophthalmic imaging technologies continue to expand their capabilities, eye care practitioners like Dr. Ramin Tadayoni have an increasing abundance of data points necessary for managing diabetic eye disease over time.

Learn more about the ZEISS Retina Workflow : https://zeiss.ly/yt_ZEISS-Retina-Workflow

*The doctor featured in this video has a contractual or other financial relationship with Carl Zeiss Meditec, Inc. and its affiliates and has received financial support."
Be the first to comment